Capricorn Fund Managers’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Capricorn Fund Managers's TVTX Position: Q3 2026 in Review
Capricorn Fund Managers sold out of Travere Therapeutics (TVTX) in Q3 2026, closing a stake of 321,721 shares — an estimated $18.3M sold.
Capricorn Fund Managers first reported a position in TVTX in Q2 2026 and held it in 1 quarter. The position peaked at $18.3M in Q2 2026. 312 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Capricorn Fund Managers reported no remaining Travere Therapeutics position as of Q3 2026 after selling out during the quarter.
- Capricorn Fund Managers sold 321,721 Travere Therapeutics shares in Q3 2026, an estimated $18.3M.
- Capricorn Fund Managers first reported a position in Travere Therapeutics in Q2 2026 and held it in 1 quarter.
- Capricorn Fund Managers's Travere Therapeutics position peaked at $18.3M in Q2 2026.
- 312 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.